## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.3% in lower entry zone (3.0-6.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Strong momentum (+6.7% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($202.07)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Caxton Associates LLP Makes New $1.10 Million Investment in UFP Industries, Inc. $UFPI**
- Source: MarketBeat | 20251216T090834 | Neutral | Relevance: 64%
- Caxton Associates LLP has made a new investment of approximately $1.10 million in UFP Industries, Inc. (NASDAQ:UFPI), acquiring 11,059 shares in the second quarter. This comes as UFP Industries reported a Q2 earnings miss with $1.29 EPS vs $1.37 consensus and revenue of $1.56 billion, down 5.4% year-over-year. Analyst ratings are mixed, with a consensus "Hold" rating and a $114.25 price target.

**2. Here's Why RenaissanceRe Shares Are Attracting Prudent Investors Now**
- Source: TradingView â€” Track All Markets | 20251215T160936 | Bullish | Relevance: 64%
- RenaissanceRe Holdings Ltd. (RNR) is attracting investors due to its strong performance, including a 10% share growth in six months, increasing net premiums, investment income, and strategic acquisitions. The company also boasts robust cash generation, evident in share buybacks and dividend payouts, and is currently trading at a discount compared to the industry average. Despite these positives, investors should consider risks such as escalating expenses and high debt levels.

**3. Check out AllianzIM U.S. Large Cap Buffer20 Jan ETF's stock price (JANW) in real time**
- Source: CNBC | 20251214T120820 | Neutral | Relevance: 62%
- This article provides real-time stock price information for AllianzIM U.S. Large Cap Buffer20 Jan ETF (JANW). It includes current trading data, volume, 52-week range, and key statistics like open, high, low, and previous close prices. The article notes that there is no recent news available for this security.

**4. Stance Capital LLC Invests $1.30 Million in The Progressive Corporation $PGR**
- Source: MarketBeat | 20251215T115545 | Neutral | Relevance: 62%
- Stance Capital LLC recently acquired a new stake of 4,856 shares in The Progressive Corporation (NYSE:PGR), valued at approximately $1.30 million during the second quarter. Other institutional investors have also adjusted their holdings, with the company's stock currently trading at $234.61 with a market cap of $137.58 billion. Analysts currently give Progressive an average "Hold" rating with a consensus price target of $266.40.

**5. Morgan Stanley upgrades Lemonade stock rating to Equalweight, sets $85 target**
- Source: Investing.com | 20251216T094302 | Somewhat-Bullish | Relevance: 61%
- Morgan Stanley upgraded Lemonade Inc. (NYSE:LMND) from Underweight to Equalweight, setting an $85 price target due to consistent growth in its Car segment, improved loss ratios, and a clear path to generating EBITDA profitability by Q4 2026. The firm noted Lemonade's strong financial position with over $1 billion in cash and investments, allowing it to fund future growth without additional capital. This upgrade comes despite a softening personal auto insurance underwriting cycle, with Morgan Stanley highlighting Lemonade's significant growth opportunities compared to legacy insurers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $254 | $0 | 0% |
| 2025-12-16 | Morgan Stanley | $215 | $245 | -12% |
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-11-26 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Heavy insider selling: $11M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +6.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $55.2B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 8.7 |
| Current P/E | 7.3 |
| YoY Growth | -15.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -3.4% to 3.3% (+6.7% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.31% (CS: 82) | Strong |
| RSI_14 | 55.7 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 1.038x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $209.57
- **Stop Loss:** $202.07 (3.6% risk)
- **Target:** $220.82 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 160
- **Position Value:** $33,531.20
- **Portfolio %:** 33.53%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*